Zura Bio (ZURA) Preferred Stock Liabilities (2021 - 2024)

Zura Bio's Preferred Stock Liabilities history runs 4 years deep, the most recent figure standing at $2.4 million for Q2 2024.

• On a quarterly basis, Preferred Stock Liabilities rose 14.26% year-over-year to $2.4 million in Q2 2024; TTM through Jun 2024 was $2.4 million, a 14.26% increase from a year earlier, with the FY2023 full-year figure at $990000.0, down 92.08% from the prior year.
• Preferred Stock Liabilities climbed to $2.4 million in Q2 2024 per ZURA's latest filing, from $1.6 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $140.2 million in Q3 2022 and bottomed at $990000.0 in Q4 2023.
• The 4-year median for Preferred Stock Liabilities is $2.4 million (2024), against an average of $41.3 million.
• Across the five-year window, Preferred Stock Liabilities sank 98.61% in 2023 and grew 14.26% in 2024, its largest moves.
• Year by year, Preferred Stock Liabilities stood at $139.4 million in 2021, then tumbled by 91.03% to $12.5 million in 2022, then slumped by 92.08% to $990000.0 in 2023, then surged by 138.79% to $2.4 million in 2024.
• Per Business Quant, the three latest ZURA Preferred Stock Liabilities figures stand at $2.4 million (Q2 2024), $1.6 million (Q1 2024), and $990000.0 (Q4 2023).